Table 2

Crude risk of increasing serum concentrations of uric acid

Odds ratio for outcome

Serum uric acid concentration, μmol/L [mg/dL]

Agatston score >0 vs. Agatston score = 0

Agatston score >10 vs. Agatston score <10

Men (n = 1,211)

Quartile 1

155-291 [2.6-4.9]

1

1

Quartile 2

297-333 [5.0-5.6]

1.17

(0.71-1.95)

1.21

(0.65-2.23)

Quartile 3

339-393 [5.7-6.6]

1.56

(0.96-2.54)

1.62

(0.91-2.91)

Quartile 4

399-690 [6.7-11.6]

2.07

(1.30-3.31)

2.08

(1.19-3.67)

Women (n = 1,287)

Quartile 1

77-196 [1.3-3.3]

1

1

Quartile 2

196-226 [3.3-3.8]

1.50

(0.66-3.38)

1.49

(0.52-4.22)

Quartile 3

232-274 [3.9-4.6]

1.44

(0.65-3.23)

1.5

(0.54-4.17)

Quartile 4

280-636 [4.7-10.7]

2.47

(1.17-5.22)

2.93

(1.15-7.49)

Overall (n = 2,498)

Quartile 1

77-291 [1.3-4.9]

1

1

Quartile 2

196-333 [3.3-5.6]

1.25

(0.81-1.91)

1.27

(0.75-2.15)

Quartile 3

232-393 [3.9-6.6]

1.47

(0.98-2.22)

1.54

(0.93-2.54)

Quartile 4

280-690 [4.7-11.6]

2.11

(1.42-3.12)

2.24

(1.39-3.60)

Krishnan et al. Arthritis Research & Therapy 2011 13:R66   doi:10.1186/ar3322